Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randy Yeh

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Academic Radiology|July 2, 2023
Imaging the Side Effects of CAR T Cell Therapy: A Primer for the Practicing RadiologistSophia Huang, Dorine de Jong, Jeeban P Das, et al.
The Journal of Clinical Investigation|December 13, 2016
Prolonged red cell storage before transfusion increases extravascular hemolysisFrancesca Rapido, Gary M Brittenham, Sheila Bandyopadhyay, et al.
Transfusion|April 20, 2019
Reexamination of the chromium-51-labeled posttransfusion red blood cell recovery methodRichard O Francis, Sonia Mahajan, Francesca Rapido, et al.
Annals of Surgery|February 10, 2023
Durvalumab and PET-Directed Chemoradiation in Locally Advanced Esophageal Adenocarcinoma: A Phase Ib/II StudyDarren Cowzer, Abraham Jing-Ching Wu, Smita Sihag, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2026
Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract CancerDarren Cowzer, Henry Walch, Pranita Atri, et al.
Lancet (London, England)|December 17, 2023
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 studyChiaojung Jillian Tsai, Jonathan T Yang, Narek Shaverdian, et al.
JCO Precision Oncology|September 16, 2025
Clinical Utility and Prognostic Implications of Circulating Cell-Free DNA in Biliary Tract CancerDarren Cowzer, Madison Darmofal, Kenneth Seier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2022
Phase II Trial of Imatinib Plus Binimetinib in Patients With Treatment-Naive Advanced Gastrointestinal Stromal TumorPing Chi, Li-Xuan Qin, Bastien Nguyen, et al.
British Journal of Haematology|April 13, 2024
Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapyJoshua S Friedman, Benjamin H Durham, Anne S Reiner, et al.
Nature Medicine|November 10, 2022
Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancerJustin Jee, Emily S Lebow, Randy Yeh, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Academic Radiology|July 2, 2023
Imaging the Side Effects of CAR T Cell Therapy: A Primer for the Practicing RadiologistSophia Huang, Dorine de Jong, Jeeban P Das, et al.
The Journal of Clinical Investigation|December 13, 2016
Prolonged red cell storage before transfusion increases extravascular hemolysisFrancesca Rapido, Gary M Brittenham, Sheila Bandyopadhyay, et al.
Transfusion|April 20, 2019
Reexamination of the chromium-51-labeled posttransfusion red blood cell recovery methodRichard O Francis, Sonia Mahajan, Francesca Rapido, et al.
Annals of Surgery|February 10, 2023
Durvalumab and PET-Directed Chemoradiation in Locally Advanced Esophageal Adenocarcinoma: A Phase Ib/II StudyDarren Cowzer, Abraham Jing-Ching Wu, Smita Sihag, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2026
Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract CancerDarren Cowzer, Henry Walch, Pranita Atri, et al.
Lancet (London, England)|December 17, 2023
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 studyChiaojung Jillian Tsai, Jonathan T Yang, Narek Shaverdian, et al.
JCO Precision Oncology|September 16, 2025
Clinical Utility and Prognostic Implications of Circulating Cell-Free DNA in Biliary Tract CancerDarren Cowzer, Madison Darmofal, Kenneth Seier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 18, 2022
Phase II Trial of Imatinib Plus Binimetinib in Patients With Treatment-Naive Advanced Gastrointestinal Stromal TumorPing Chi, Li-Xuan Qin, Bastien Nguyen, et al.
British Journal of Haematology|April 13, 2024
Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapyJoshua S Friedman, Benjamin H Durham, Anne S Reiner, et al.
Nature Medicine|November 10, 2022
Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancerJustin Jee, Emily S Lebow, Randy Yeh, et al.
Pageof 8